| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 10.569 | 25.679 | 57.287 | 67.507 |
| Total Income - EUR | - | - | - | - | - | 0 | 10.569 | 35.723 | 102.841 | 180.012 |
| Total Expenses - EUR | - | - | - | - | - | 34 | 2.258 | 25.415 | 86.590 | 163.746 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -34 | 8.311 | 10.307 | 16.251 | 16.266 |
| Net Profit/Loss - EUR | - | - | - | - | - | -34 | 8.000 | 9.862 | 13.079 | 11.133 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Kordax Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 14.439 | 13.118 | 31.288 | 191.017 | 121.698 |
| Current Assets | - | - | - | - | - | 73 | 916 | 10.917 | 40.633 | 83.991 |
| Inventories | - | - | - | - | - | 0 | 679 | 681 | 958 | 1.518 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 34.761 | 81.640 |
| Cash | - | - | - | - | - | 73 | 238 | 10.236 | 4.914 | 832 |
| Shareholders Funds | - | - | - | - | - | 7 | 8.007 | 11.826 | 24.869 | 35.863 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 14.505 | 6.027 | 30.379 | 111.954 | 107.478 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 94.827 | 62.348 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Kordax Medical S.r.l.